ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS
Clinical trials for ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost muscle disease treatment
Disease control Recruiting nowThis study is testing whether adding a new drug called empasiprubart to an existing treatment (efgartigimod) can better control symptoms of myasthenia gravis. It will involve about 70 adults with a specific type of this muscle-weakening disease who have had only a partial improve…
Matched conditions: ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for Muscle-Weakening disease: multiple drug trials launch
Disease control Recruiting nowThis study aims to test the safety and effectiveness of several different drug combinations for people with myasthenia gravis, a condition that causes muscle weakness. It will enroll about 70 adults who have been diagnosed with the disease and are on stable treatment. The goal is…
Matched conditions: ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS
Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC